Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

NCT07246889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection

NCT07183306 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

NCT06993480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B

NCT03585322 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection

NCT07245953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

NCT06744686 ·Status: COMPLETED ·Phase: PHASE1

Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B

NCT01533051 ·Status: UNKNOWN

This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity

NCT06746311 ·Status: COMPLETED ·Phase: PHASE1

Treatment and Prognosis of Patients With Chronic HBV Infection

NCT05392387 ·Status: RECRUITING

Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B

NCT07328711 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

NCT06277037 ·Status: RECRUITING

Research on Clinical Recovery and Maintenance Strategies for CHB

NCT06803368 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection

NCT05542979 ·Status: COMPLETED ·Phase: PHASE1

Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B

NCT00324961 ·Status: COMPLETED ·Phase: PHASE4

Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase

NCT05661786 ·Status: RECRUITING

Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B

NCT05808374 ·Status: UNKNOWN ·Phase: PHASE1

Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

NCT04896255 ·Status: RECRUITING

Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects

NCT05310487 ·Status: COMPLETED ·Phase: PHASE1

A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B

NCT03714152 ·Status: COMPLETED ·Phase: PHASE1

Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients

NCT03013556 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA

NCT03770624 ·Status: UNKNOWN ·Phase: PHASE1

A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531

NCT02956850 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients

NCT04480294 ·Status: UNKNOWN ·Phase: PHASE1

A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

NCT06311734 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B

NCT03625102 ·Status: COMPLETED ·Phase: PHASE2